Tylenol manufacturer Kenvue Brands LLC sent a letter to the Food and Drug Administration, criticizing demands that the drug's label be changed to reflect greater safety warnings.
The Food and Drug Administration (FDA) announced that it has initiated the process of changing the labeling for Tylenol in light of President Trump's announcement that acetaminophen is linked to autism development when used during pregnancy.
The British Labour government strongly rebuked President Donald Trump’s recent warning about a potential link between autism and the use of paracetamol during pregnancy. Health Secretary Wes Streeting dismissed the claim during a Tuesday morning appearance on ITV, advising the public to trust the National Health Service (NHS) and British medical professionals over the U.S. President.
